Switching from Bupropion (Wellbutrin) to Sertraline (Zoloft)
When switching from bupropion to sertraline, taper bupropion over 10-14 days to minimize withdrawal symptoms, then initiate sertraline at 25-50 mg daily after completing the taper. 1
Tapering Bupropion
- Discontinue bupropion gradually over 10-14 days to limit withdrawal symptoms 1
- For patients on bupropion XL 300 mg daily, decrease to 150 mg once daily before complete discontinuation 2
- For patients on bupropion SR 300 mg daily (150 mg twice daily), reduce to 150 mg once daily for several days before stopping 2
- Monitor for potential withdrawal effects during the taper, though bupropion has relatively low discontinuation syndrome risk compared to SSRIs 3
Initiating Sertraline
- Start sertraline at 25-50 mg daily after completing the bupropion taper 1
- Sertraline is well tolerated and has less effect on metabolism of other medications compared to other SSRIs 1
- The maximum dose is 200 mg per day, taken morning or evening 1
- Allow at least 4-8 weeks for full therapeutic trial at adequate dosing 1
Key Clinical Considerations
Avoid cross-tapering or overlapping these medications. Unlike switching between SSRIs where cross-tapering may be appropriate, bupropion and sertraline have distinct mechanisms (bupropion inhibits norepinephrine/dopamine reuptake; sertraline inhibits serotonin reuptake), making sequential switching preferable 4, 5
Monitoring During the Switch
- Monitor for depressive symptom worsening during the medication-free interval or early sertraline treatment 1
- Watch for common sertraline side effects including nausea, diarrhea, sexual dysfunction, and gastrointestinal disturbances 3, 6
- Sertraline has higher rates of diarrhea compared to bupropion 6
- Sexual dysfunction is significantly more common with sertraline than bupropion 6
Special Warnings
- Do not combine with MAOIs: Allow at least 14 days between discontinuing an MAOI and starting sertraline, or vice versa 2
- Sertraline, paroxetine, and fluvoxamine are associated with discontinuation syndrome if stopped abruptly in the future 3
- Monitor for suicidal ideation, particularly in younger patients, as SSRIs carry increased risk for nonfatal suicide attempts 6
Expected Outcomes
After switching from bupropion to sertraline, approximately 20-25% of patients achieve remission with the new medication 7, 8. Response rates (≥50% symptom reduction) range from 26-28% 7. These modest success rates reflect the challenging nature of treatment-resistant depression and underscore realistic expectations when switching antidepressants 7, 8.
If sertraline proves ineffective after 6-12 weeks at therapeutic doses, consider alternative strategies including switching to a different antidepressant class or augmentation approaches 9, 7.